# DEM Bio

**Canonical:** https://apis.io/providers/dem-bio/  
**Website:** https://dembiopharma.com/  
**APIs profiled:** 0

DEM BioPharma is a Cambridge, Massachusetts biotechnology company developing first-in-class cancer therapeutics that target the signals solid tumors use to evade immune destruction. The company pioneers next-generation macrophage and innate-immune immunotherapies discovered through its proprietary CHoMP (Co-culture with Human Myeloid Phagocytes) functional-genomics platform, which uses CRISPR-based screening to identify novel "don't-eat-me" and activating targets on myeloid cells. DEM launched in 2022 with $70M in Series A financing and is backed by Longwood Fund, Emerson Collective, Pfizer Ventures, Astellas, and Insight Partners. Added to the API Evangelist network as a portfolio-company profile; DEM publishes no public developer or API surface at this time.

## Kin Score — 6.4 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 6.4).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Dem Bio Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotech Therapeutics, Oncology, Immunotherapy, Cancer, CRISPR, Drug Discovery, Functional Genomics, Macrophage

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/dem-bio/). Scores are computed from the provider's own public artifacts under a published rubric.